Supplementary Table S5. Individual Patient Data Meta-Analysis - Randomized Trials from FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia
crossref(2023)
Abstract
Supplemental Table 5 describes the 5 randomized trials of GO plus chemotherapy reviewed as part of the safety assessment of GO in combination with chemotherapy.
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined